GDF15 and FGF21 have been found to be associated with a range of non-mitochondrial diseases, including cancer, obesity, renal diseases, diabetes, liver diseases, and non-mitochondrial myopathies (18, 36–38). Here, FGF21 is linked to inborn mitochondrial metabolism disorder.